Objective: muscle receptors and selected anabolic effects have been identified for both insulin-like growth factor I (IGF-D and 1,25-dihydroxyvitamin D (l,25(OH)2D3). The aim of the present study was to test the hypothesis that the decreasing concentrations of these endocrine factors might be involved in the decline in muscle function that characterizes normal human ageing. Design: cross-sectional study. Study participants: a community-based sample of 245 healthy elderly women aged 70-90 years. Exclusion criteria were diseases or medications known to affect muscle function or the somatotrophic axis. Measurements: knee extension strength was evaluated using an isokinetic dynamometer. A standardized questionnaire was used to assess habitual physical activity. IGF-I and 1,25(OH)2D3 were measured by radioimmunoassay. Vitamin D binding protein (DBP) was measured by single radial immunodiffusion and the free 1,25(OH)2D3 concentration calculated as the molar ratio of total 1,25(OH)2D3 to DBP Results: the differences in isometric and isokinetic strength over the age range were equivalent to losses of 0.9-2.4% per year. However, no relationship was found between the somatotrophic axis or vitamin D status and knee extension strength, despite markedly decreasing concentrations of circulating IGF-I and free I ,25(OH)2D3 with age. Conclusion: levels of circulating IGF-I and free 1,25(OH)2D3 appear not to be involved in the loss of muscle function that characterizes normal human ageing.
Introduction
Both cross-sectional [1] [2] [3] [4] [5] [6] [7] and longitudinal [8, 9) studies have consistently documented an age-related decline in muscle function, affecting static (isometric) as well as dynamic (isokinetic), and proximal as well as distal muscle strength. This loss is of particular clinical significance, since muscle dysfunction and associated mobility impairment increase the risk of falls [10) , fractures [II) and functional dependency [6) .
Among other factors [12) , muscle weakness in elderly people could be a consequence of alterations in hormone balance. In particular, ageing is associated with lowered serum levels of 1,25-dihydroxyvitamin D (calcitriol; 1,25(OH)2D3) [13) and insulin-like growth factor I (IGF-I) [14) , endocrine factors considered to be anabolic for muscle tissue [IS, 16) . Therefore, it is tempting to speculate that these age-related endocrine deficiencies might affect muscle performance. However, the exact role of I ,25(OH)2D" and IGF-I in human muscle cell physiology and pathophysiology remains to be clarified.
The aim of the present study was to investigate the extent to which both -potentially reversible [17, 18] -endocrine deficiencies contribute to the agerelated decline in muscle function. To this end, knee extension strength and serum levels of 1,25(OH)2D3 and IGF-I were measured in a well-defined communitybased sample of healthy older women.
Subjects and methods

Study population
Volunteers were recruited from 50 general practices in the province of Brabant, Belgium. Assessment of eligibility for participation was based on screening by questionnaire, a thorough medical examination and a measurement of basal plasma glucose and thyrotropin concentration. Women had to be over 70 years of age, non-institutionalized, functionally independent and free from diseases or medications known to affect the musculo-skeletal system or the somatotrophic axis.
Subjects were excluded if they met any of the following criteria: (i) metabolic bone disease, (ii) rheumatoid arthritis and/or (physician-diagnosed) osteoarthritis, (iii) ischaemic and/or valvular heart disease, (iv) chronic bronchitis and/or emphysema, (v) cerebrovascular disease, ever, affecting the relevant limb, (vi) non-arthroscopic joint surgery, ever, in the relevant limb, (viii) diabetes mellitus, whether controlled or uncontrolled, (vii) thyrOid disease, whether controlled or uncontrolled, (ix) systolic blood pressure :::: 200 mmHg and/or diastolic pressure:::: 100mmHg, (x) being on daily medication, including vitamin D supplements, or (xi) ever having used glucocorticoids (::::5 mg prednisone or equivalent per day), oestrogens (or oestrogen-related drugs) or anabolic steroids for more than 3 months.
Subjects not meeting any of the exclusion criteria (35% of the volunteers) were referred to the Leuven University Centre for Metabolic Bone Diseases. After reassessing the exclusion criteria, all tests were performed on the same day and in a set order. From 1 September to 31 October, 245 independent, healthy volunteers, aged 70-90 years, were identified. Informed consent was obtained from all the women and all procedures were approved by the institutional ethical committee.
Interview
Study participants answered interviewer-administered questionnaires. A standardized interview [19] was used to obtain basic demographic variables, social and lifestyle characteristics and medical information. Habitual physical activity was assessed according to Sallis et al. [20] , providing an estimate of the kcal/kg expended during the previous week in moderate, hard or very hard activity.
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Anthropometric measures
Anthropometric measurements were made of height and body weight.
Biochemical measures
Fasting blood samples were collected from all subjects. IGF-I was measured by a previously described radioimmunoassay after acid -ethanol extraction [21] . 1,25(OH)2D3 was measured by radioimmunoassay and vitamin D binding protein (DBP) by single radial immunodiffusion. Details of methodology and validation have been previously reported [21] [22] [23] .
The free 1,25(OH)2D3 index was calculated as the molar ratio of total 1,25(OH)2D3 to DBP [24] . This index has been previously documented to represent an adequate estimation ofthe free concentration [25] .
Muscle strength assessment
Isometric and isokinetic strength was evaluated in the knee extensors of the right lower extremity, primarily the quadriceps. Knee extension strength was measured using an isokinetic dynamometer (Cybex II, Lumex Inc., Ronkonkoma, NY, USA) according to the standardized procedures from the manufacturer. All tests were demonstrated by the assessor before being performed by the volunteer. Isokinetic strength was measured at different angular velocities (60 0 /s and 90°/ s), the highest value of three measurements taken as maximum isokinetic strength for each angular velOCity. Maximum isokinetic strength was determined as the average of the maximum strength at the different angular velocities. Isometric strength was measured at different angles (90° and 60°) as the highest value of three attempts. Maximum isometric strength was determined as the average of the maximum strength at the different angles. To determine the short-term reproducibility for each isokinetic velocity and for isometric strength, duplicate measurements (with a minimum interval of 1 h) were performed in a random sample of 20 subjects with a mean age of 76 years. Assessed in this manner, the coefficients of variation ranged from 2.2 to 3.4%.
Statistical analysis
Univariate regression was used to assess the effect of age on habitual physical activity, circulating IGF-I and free 1,25(OH)2D3. To evaluate the linear relationship between quadriceps strength and age, habitual physical activity, circulating IGF-I and free 1,25(OH)2D3' both univariate and multivariate regression analyses were performed. A percentage apparent loss of quadriceps strength per year was calculated by dividing the slope of the regression line by the predicted value at the mid-point of the age range (age 80; %80 p.a.). All statistical analyses were performed 
Results
Characteristics of the population
Subject characteristics, biochemical data and the results of the knee extension strength measurements are shown in Table 1 .
Age-associated changes in physical activity, circulating IGF-I and free 1,25(OHhD l
Habitual physical activity (r = -0.28, P < 0.001) was negatively related to age. Circulating IGF-I (r = -0.21, P < 0.01) and free 1,25(OH)2D3 concentrations (r = -0.17, P < 0.01) also decreased as a function of age.
Relationship of knee extension strength with age
All isometric and isokinetic parameters were negatively related to age ( Table 2) .
Determinants of knee extension strength
As there was a strong correlation between maximum isokinetic and maximum isometric strength (r = 0.77, P < 0.001), an overall index of knee extension strength was determined as the mean of these two values. Univariate and multivariate regression coefficients of potential determinants on strength are shown in Table  3 . In univariate regression, age ( 
Discussion
These findings confirm and extend previous observations indicating a significant age-associated decrease in • flit t.
.o.. both isometric and isokinetic knee extension strength [1] [2] [3] [4] [5] [6] [7] . Annual percentage reductions were -0.9% and -2.4%, respectively. These rates of decline are in line with those reported in previous cross-sectional studies and suggest a continuing loss of muscle performance throughout life. In this regard, it should be noted that our participants were volunteers and not a random sample of the general elderly population. All studies of human ageing are faced with the problem of defining normality in a population with a high prevalence of chronic disease. In order to study age-related processes and to provide reference values against which to judge data from elderly patients, disease-free subjects have to be selected [26] . This requires tightly defined, predetermined criteria. Our subjects were not selected as representative of the overall elderly population but to allow us to study the effects of healthy ageing. Receptors for 1,25(OH)2D3 and functional responsiveness to 1,25(OH)2D3 at physiological hormone concentrations have been demonstrated in cultured human muscle cells [27, 28] . Various lines of evidence suggest a role of 1,25(OH)2D3 in the regulation of intracellular calcium fluxes and the synthesis of the actomyosin contractile complex, therefore affecting the contraction-relaxation cycle [15, 29, 30] . Similarly, receptors for IGF-I have been identified in human muscle tissue [16] and IGF-I has been shown to promote the synthesis of different muscle protein components [16, 31] . However, the findings of the present study do not support the hypothesis that decreased secretion of IGF-I or 1,25(OH)2D3 contributes to the age-associated decline in muscle strength. In fact, there was no evidence for a relation of vitamin D status or the somatotrophic axis to muscle strength in ageing women, despite markedly declining concentrations of circulating IGF-I and free
1,25(OH)P3'
High-intensity resistance training has been shown to increase muscle mass and strength in elderly subjects [32 -38] and may even improve the ability to perform functional activities [39, 40] . However, whether a high level of customary activity might provide protection against some of the age-associated loss of muscle performance remains unclear [6, 41, 42] . In the present study, the decrease in activity score did not add significantly to the effect of age on knee extension strength, suggesting that higher levels of physical activity may not be sufficient to maintain muscle function in ageing women.
There are several potential limitations to our analysis which may affect the inferences derived from these data. We did not measure the major IGF binding protein, IGF binding protein-3 (lGFBP-3). Circulating levels of IGF-I and IGFBP-3 are principally regulated by the same factors, but levels of IGFBP-3 are more stable [43] . Consequently, significant relationships as a result of long-term growth hormone dependence may be more easily detected for the binding protein. Moreover, our subjects were not selected as representative of the overall elderly population but to allow us to study correlates of muscle strength in the absence of confounding diseases and medications. Therefore, the results cannot be generalized, particularly not to more frail, nonambulatory elderly women who live in nursing homes and are more likely to be severely deficient in vitamin D [17] and growth hormone [44] .
In addition, our conclusions are based upon crosssectional data and we acknowledge that confirmation would require a longitudinal study design. Since muscle strength changes slowly in ageing women, the point-in-time values may be correlated less strongly with contemporary hormone levels than with those of preceding years. Finally, our study was not designed to address the extent to which the decline in muscle function associated with healthy ageing might respond to growth hormone or vitamin D therapy. Only doubleblind, placebo-controlled intervention trials can provide an answer to this important question.
In conclusion, ageing in healthy women is associated with a significant decrease in both isometric and isokinetic knee extension strength. However, levels of circulating IGF-I and free 1,25(OH)zD 3 appear not to be involved in this age-related loss of muscle function.
Key points
• Ageing in healthy women is associated with a continuing loss of muscle performance.
• Levels of circulating insulin-like growth factor I and free 1,25-dihydroxyvitamin D are unlikely to be involved in this decline.
• Higher levels of customary activity may not be sufficient to maintain muscle strength in ageing women.
